ProCE Banner Series

A Treatment Option For Patients with ESR1-mutated, ER+/HER2- mBC Following Progression on Initial ET +/- a CDK4/6i

Join us to gain insights on a second line treatment in ESR1 mutated, ER+/HER2-mBC.

Key Takeaways:
- Understanding the need for ESR1 mutation testing at each progression, and how results can inform treatment options

All Events

A Treatment Option For Patients with ESR1-mutated, ER+/HER2- mBC Following Progression on Initial ET +/- a CDK4/6i

Past Events

July

31

2024

12:15 PM - 12:45 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Andrew D. Seidman, MD

Attending Physician
Breast Cancer Medicine Service
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weill Medical College of Cornell University
New York, New York